Inactive Instrument
Probi AB Share Price OTC Markets
Stocks
PBBIF
SE0001280355
Pharmaceuticals
OTC Markets Traded| 1 day | +31.67% |
| Manager | Title | Age | Since |
|---|---|---|---|
Anita Johansen
CEO | Chief Executive Officer | 54 | 07/12/2022 |
Johan Flink
DFI | Director of Finance/CFO | 49 | 31/07/2025 |
James Henson
COO | Chief Operating Officer | 39 | 31/12/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Jörn Andreas
BRD | Director/Board Member | 45 | 31/12/2013 |
| Chairman | 62 | 31/03/2015 | |
| Director/Board Member | 64 | 03/05/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +31.67% | +85.88% | - | - | 33.68M | ||
| -1.52% | -7.23% | +57.90% | +108.72% | 1,031B | ||
| -0.82% | -2.63% | +50.05% | +64.43% | 641B | ||
| +0.37% | -3.06% | +21.87% | +74.48% | 453B | ||
| -2.10% | -6.56% | +33.01% | +32.96% | 349B | ||
| +4.39% | +1.83% | +27.12% | +44.53% | 290B | ||
| -1.14% | -2.01% | +0.14% | +11.29% | 252B | ||
| -0.59% | -3.15% | +49.83% | +67.70% | 232B | ||
| +0.44% | -1.94% | -19.62% | -53.93% | 201B | ||
| +0.45% | -0.27% | +29.84% | +91.34% | 181B | ||
| Average | +3.11% | -2.98% | +27.79% | +49.06% | 403.31B | |
| Weighted average by Cap. | -0.45% | -3.97% | +36.95% | +64.97% |
Employees
-
Sector
Pharmaceuticals
















